These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7122665)

  • 1. Effects of fluphenazine decanoate (a long-acting phenothiazine) on serum prolactin and amphetamine-induced behavioural changes.
    Merali Z; Toth G
    Pharmacol Biochem Behav; 1982 Jul; 17(1):25-30. PubMed ID: 7122665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin levels and amphetamine-induced behavioural changes following fluphenazine decanoate administration.
    Merali Z
    Prog Neuropsychopharmacol; 1981; 5(5-6):603-7. PubMed ID: 7339653
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine agonists on Cebus apella monkeys with previous long-term exposure to fluphenazine.
    Lifshitz K; O'Keeffe RT; Linn GS; Lee KL; Camp-Bruno JA; Suckow RF
    Biol Psychiatry; 1997 Mar; 41(6):657-67. PubMed ID: 9066989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and electroencephalographic effects of a depot type neuroleptic fluphenazine decanoate, in rats.
    Yamamoto T; Ueki S
    J Pharmacobiodyn; 1989 Nov; 12(11):681-92. PubMed ID: 2632765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting neuroleptic use for reproductive management of non-domestic ungulates using the domestic goat (Capra hircus) as a model.
    Weiss RB; Schook MW; Wolfe BA
    Zoo Biol; 2014; 33(3):204-11. PubMed ID: 24644127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bombesin-induced behavioural changes: antagonism by neuroleptics.
    Merali Z; Johnston S; Zalcman S
    Peptides; 1983; 4(5):693-7. PubMed ID: 6657513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral consequences of long-term treatment with neuroleptic drugs.
    Iversen SD; Howells RB; Hughes RP
    Adv Biochem Psychopharmacol; 1980; 24():305-13. PubMed ID: 6105782
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous hyperprolactinaemia enhances amphetamine- and apomorphine-induced stereotypy.
    Drago F; Van Ree JM; Bohus B; de Wied D
    Eur J Pharmacol; 1981 Jun; 72(2-3):249-53. PubMed ID: 7195817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopaminergic system(s) in mediation of the behavioural effects of bombesin.
    Merali Z; Johnston S; Sistek J
    Pharmacol Biochem Behav; 1985 Aug; 23(2):243-8. PubMed ID: 3933020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological studies of long-acting phenothiazines with particular reference to fluphenazine decanoate (author's transl)].
    Chen PC
    Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):871-83. PubMed ID: 570538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats.
    Kittner H; Krügel U; Illes P
    Neuroscience; 2001; 102(2):241-3. PubMed ID: 11166110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
    Sershen H; Harsing LG; Hashim A; Lajtha A
    Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical and behavioural correlates of the interaction between amphetamine and delta 9-tetrahydrocannabinol in the rat.
    Lew EO; Richardson JS
    Drug Alcohol Depend; 1981 Sep; 8(2):93-101. PubMed ID: 6274603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral characterization of d- and l-amphetamine: neurochemical implications.
    Segal DS
    Science; 1975 Oct; 190(4213):475-7. PubMed ID: 1166317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
    Lewis MH; Widerlöv E; Knight DL; Kilts CD; Mailman RB
    J Pharmacol Exp Ther; 1983 Jun; 225(3):539-45. PubMed ID: 6134814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does tolerance develop to low doses of d- and l-amphetamine on locomotor activity in rats?
    Weston PF; Overstreet DH
    Pharmacol Biochem Behav; 1976 Dec; 5(6):645-9. PubMed ID: 1023233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests.
    Oka M; Karasawa T; Ochi Y; Asano K; Terauchi Y; Kadokawa T
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):289-302. PubMed ID: 4062440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Lemberger L; Kellams JJ; Small JG; Rowe H
    Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy.
    Heresco-Levy U; Greenberg D; Lerer B; Javitt DC; Brown WA
    Isr J Psychiatry Relat Sci; 1997; 34(4):281-9. PubMed ID: 9409085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.